UNSPSC 85722036: Removal of autologous tissue substitute from left metatarsal-tarsal joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of autologous tissue substitute from left metatarsal-tarsal joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SPL37Z

UNSPSC 85722036 (Removal of autologous tissue substitute from left metatarsal-tarsal joint, percutaneous approach), a Commodity code, shows little relevant recent activity under its nominal scope. The six recent state and local opportunities tagged to this code procure disability medical evaluations, surgical benefit carve-out administration, occupational medical surveillance, emergency and specialty hospital care for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve orthopedic joint procedures or tissue removal. The code's narrow clinical specificity does not align with the actual health care procurement taking place under it, suggesting either a tagging error or that state and local agencies have applied this procedural code as a catch-all for broader medical services contracting.

The geographic spread of the mislabeled opportunities spans Arizona (City of Phoenix Retirement Office), California (City of Long Beach and County of Santa Clara Health System), Washington (Washington State Department of Transportation), Texas (Harris County Juvenile Probation Department), and Florida (Collier County Board of County Commissioners). The most concrete opportunity on record is the City of Phoenix Retirement Office's RFP 26001 for independent medical evaluation services, due October 16, 2026, with a total maximum contract value of $750,000 over five years beginning February 3, 2027; the Washington State Department of Transportation's RFP 20260825 for occupational medical surveillance, due October 9, 2026, also offers a two-year term with five one-year extension options. Business development professionals should verify coding accuracy with issuing bodies before pursuing work under this Commodity code — the current tagging pattern does not support the code's clinical definition.